Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Linton

Showing results (261-270 of 265) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 265 results.
Haematologica|April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL studyMarie José Kersten, Martin Dreyling, Kim M Linton, et al.
Leukemia|May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
The Lancet. Oncology|December 14, 2024
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational studyAnna Santarsieri, Emily Mitchell, My H Pham, et al.
Cancer Cytopathology|January 10, 2022
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter studyElena Vigliar, Pasquale Pisapia, Filippo Dello Iacovo, et al.
Nature|March 10, 2001
Initial sequencing and analysis of the human genomeE S Lander, L M Linton, B Birren, et al.
Pageof 27

Showing results (261-270 of 265) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 265 results.
Haematologica|April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL studyMarie José Kersten, Martin Dreyling, Kim M Linton, et al.
Leukemia|May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
The Lancet. Oncology|December 14, 2024
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational studyAnna Santarsieri, Emily Mitchell, My H Pham, et al.
Cancer Cytopathology|January 10, 2022
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter studyElena Vigliar, Pasquale Pisapia, Filippo Dello Iacovo, et al.
Nature|March 10, 2001
Initial sequencing and analysis of the human genomeE S Lander, L M Linton, B Birren, et al.
Pageof 27